Eaton Vance Ohio Municipal Income Trust (EVO) News Today → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free EVO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsHeadlinesStock AnalysisAnalyst ForecastsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBayer and Evotec Collaborate to Advance Precision Cardiologyfinance.yahoo.com - April 30 at 3:17 AMEvotec welcomes Aurélie Dalbiez as Chief People Officerfinance.yahoo.com - April 17 at 2:28 AMEvotec (ETR:EVT shareholders incur further losses as stock declines 3.7% this week, taking three-year losses to 59%finance.yahoo.com - March 18 at 10:38 AMEvotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapiesfinance.yahoo.com - January 10 at 10:20 AMEvotec-partner Jingxin Receives Approval for EVT201 in Chinafinance.yahoo.com - December 6 at 4:14 AMEvotec SE's (ETR:EVT) largest shareholders are individual investors with 47% ownership, institutions own 34%finance.yahoo.com - December 4 at 7:23 AMEvotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets Dayfinance.yahoo.com - November 15 at 2:46 AMDewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipelinefinance.yahoo.com - November 7 at 7:58 AMEvotec and Dewpoint Therapeutics Enter Strategic Partnership in Oncologyfinance.yahoo.com - November 7 at 7:58 AMEvotec SE Reports Results for the First Half-year 2023 and Provides Corporate Updatesfinance.yahoo.com - August 29 at 1:52 AMETX Eaton Vance Municipal Income 2028 Term Trustseekingalpha.com - August 24 at 4:12 PMEvotec SE Reports First Half-Year 2023 Results on 29 August 2023finance.yahoo.com - August 22 at 9:55 AMEvotec Provides Update on Financial Impact of Cyber-Attackfinance.yahoo.com - July 28 at 8:35 AMEvotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnershipfinance.yahoo.com - July 11 at 4:41 AMJust - Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies Programfinance.yahoo.com - July 5 at 7:57 AMEvotec Receives Milestone Payment for First Patient Dosed in Phase I Study of Bayer Kidney Disease Programmefinance.yahoo.com - June 29 at 4:38 AMUPDATE 1-European shares dip on rate jitters, banks risefinance.yahoo.com - June 8 at 8:13 AMEvotec Presents Sustainability Strategyfinance.yahoo.com - June 5 at 3:26 AMEvotec publishes Annual Report 2022 and Quarterly Statement for Q1 2023finance.yahoo.com - May 12 at 11:09 PMJust - Evotec Biologics Enters Strategic Biosimilars Partnership with Sandozfinance.yahoo.com - May 9 at 4:36 PMSuccessful Results Using Sernova’s Cell Pouch System™ with Evotec’s iPSC-Derived Islet-like Clusters for Type 1 Diabetes Presented at the 4th IPITA / HSCI / JDRF Summitfinance.yahoo.com - April 24 at 8:42 PMEvotec (ETR:EVT) pulls back 5.0% this week, but still delivers shareholders notable 6.1% CAGR over 5 yearsfinance.yahoo.com - April 17 at 9:48 AMCyber Attack on Evotecfinance.yahoo.com - April 7 at 9:49 AMEvotec SE to Announce Preliminary Financial Results for Fiscal Year 2022 on 28 March 2023finance.yahoo.com - March 21 at 7:27 AMEvotec Receives € 150 m Loan from European Investment Bankfinance.yahoo.com - February 10 at 9:16 AMEvotec Announces Agreement with Janssen to Develop Immune-Based Therapiesfinance.yahoo.com - January 26 at 3:20 AMEaton Vance National Municipal Income Cmorningstar.com - January 21 at 8:09 PMEaton Vance SC Municipal Income Amorningstar.com - January 14 at 8:32 PMSernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetesfinance.yahoo.com - January 10 at 9:14 AMDoes Evotec SE (EVO) Have Good Long-Term Growth Prospects?finance.yahoo.com - December 21 at 2:54 PM8% Yield Via This Leveraged Loan CEF From Eaton Vanceseekingalpha.com - November 26 at 2:38 AMInvestors in Evotec (ETR:EVT) have unfortunately lost 53% over the last yearfinance.yahoo.com - November 8 at 7:51 AMEvotec Enters Partnership with Hannover Medical School to Create Molecular Patient Database in Autoimmune Diseasesfinance.yahoo.com - October 25 at 5:50 AMEvotec launches PanOmics Data Analysis Platform PanHunter at Bio-IT Worldfinance.yahoo.com - October 18 at 2:39 AMAdapsyn Bioscience Inks Collaboration Pact With Evotecfinance.yahoo.com - September 21 at 2:44 PMEvotec Initiates Ground-Breaking for New Biologics Facility J.POD(R) Toulouse, France (EU)finance.yahoo.com - September 16 at 10:04 AMEvotec Expands Clinical and Commercial Drug Substance Manufacturing with Acquisition of Central Glass Germanyfinance.yahoo.com - August 25 at 2:54 AMJust - Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303finance.yahoo.com - August 10 at 2:13 AMEvotec SE Reports Results of Annual General Meeting 2022finance.yahoo.com - June 22 at 5:00 PMEvotec (EVO) Inks Drug Discovery Collaboration Deal With J&Jfinance.yahoo.com - June 15 at 2:54 PMExscientia -Evotec Cancer Therapy Shows Encouraging Action In Healthy Volunteersfinance.yahoo.com - June 14 at 5:24 PMEvotec Enters a Drug Discovery Collaboration with Janssenfinance.yahoo.com - June 14 at 2:21 AMEvotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatologyfinance.yahoo.com - May 19 at 3:52 AMSernova, Evotec Join Forces To Develop 'Functional Cure' For Diabetesfinance.yahoo.com - May 17 at 5:43 PMEvotec SE to Announce Results for the First Quarter 2022 on 11 May 2022finance.yahoo.com - May 4 at 8:55 AM‘Copycatting TikTok is a big trend,’ analyst says after Snap earningsfinance.yahoo.com - April 25 at 11:35 PMInsider Selling at Snap (NYSE:SNAP) Shows no Signs of Slowing Downfinance.yahoo.com - April 25 at 11:35 PMSnap posts earnings loss in Q1 following Apple ad changesfinance.yahoo.com - April 22 at 10:44 AMEvotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibbfinance.yahoo.com - April 8 at 3:07 AMEvolution goes live on day one of Ontario online gaming market with multiple operatorsfinance.yahoo.com - April 4 at 12:17 PM Get Eaton Vance Ohio Municipal Income Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Never use this word on your phone (FBI could be watching) (Ad)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions... Watch my unredacted video about what I think is coming next right here EVO Media Mentions By Week EVO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVO News Sentiment▼0.000.43▲Average Medical News Sentiment EVO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVO Articles This Week▼10▲EVO Articles Average Week Get Eaton Vance Ohio Municipal Income Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Structure Therapeutics News Today Agios Pharmaceuticals News Today Amneal Pharmaceuticals News Today Syndax Pharmaceuticals News Today Galapagos News Today Catalyst Pharmaceuticals News Today Schrödinger News Today NewAmsterdam Pharma News Today Rocket Pharmaceuticals News Today Evotec News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:EVO) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eaton Vance Ohio Municipal Income Trust Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
